<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee180385e76">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2007-09-07</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>14 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-07-1201R</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-1201R</identifier>
<identifier type="local">P0b002ee180385e76</identifier>
<identifier type="former package identifier">f:d071201r</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-07-1201R</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-07-1201R</accessId>
 <reportNumber>GAO-07-1201R</reportNumber>
 <subject>Drugs</subject>
 <subject>Elderly persons</subject>
 <subject>Health care programs</subject>
 <subject>Medicare</subject>
 <subject>Pharmaceutical industry</subject>
 <subject>Prescription drugs</subject>
 <subject>Price indexes</subject>
 <subject>Prices and pricing</subject>
 <subject>Program evaluation</subject>
 <subject>Medicare Part D</subject>
 <type>Correspondence</type>
 <accountNo>A75928</accountNo>
</extension>
<titleInfo>
 <title>Prescription Drugs: Trends in Usual and Customary Prices for Drugs Frequently Used by Medicare and Non-Medicare Health Insurance Enrollees</title>
</titleInfo>
<abstract>Prescription drug spending as a share of national health
expenditures increased from 8.9 percent in 2000 to 10.1 percent  
in 2005--among the fastest growing segments of health care	 
expenditures--and prescription drug prices outpaced inflation	 
during the same period. Rising prescription drug prices can	 
affect consumers, employers, and federal and state governments.  
Federal policymakers are particularly concerned about rising drug
prices as the federal government has assumed greater financial	 
responsibility for prescription drug expenditures with the	 
introduction of a prescription drug benefit to Medicare enrollees
in January 2006, known as Medicare Part D. Medicare enrollees are
also responsible for a share of drug costs under the Medicare	 
Part D program. As an update to our 2005 report, this report	 
responds to the request from Congress for information on trends  
in retail prices--known as usual and customary prices--for	 
prescription drugs frequently used by Medicare enrollees and	 
non-Medicare health insurance enrollees. This report focuses on  
(1) usual and customary price trends from January 2004 through	 
January 2007, and (2) usual and customary price trends from	 
January 2000 through January 2007 for the subset of drugs that	 
were included in both our 2005 report and the current report.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-07-1201R/html/GAOREPORTS-GAO-07-1201R.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-07-1201R/pdf/GAOREPORTS-GAO-07-1201R.pdf</url>
</location>
<identifier type="preferred citation">GAO-07-1201R</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-1201R</url>
</location>
<note>Correspondence</note>
<extension>
 <searchTitle>GAO-07-1201R; Prescription Drugs: Trends in Usual and Customary Prices for Drugs Frequently Used by Medicare and Non-Medicare Health Insurance Enrollees;
            </searchTitle>
</extension>
<subject>
 <topic>Drugs</topic>
 <topic>Elderly persons</topic>
 <topic>Health care programs</topic>
 <topic>Medicare</topic>
 <topic>Pharmaceutical industry</topic>
 <topic>Prescription drugs</topic>
 <topic>Price indexes</topic>
 <topic>Prices and pricing</topic>
 <topic>Program evaluation</topic>
 <topic>Medicare Part D</topic>
</subject>
</mods>